This study introduces an innovative sono‐controllable Janus hydrogel platform, GA@CaMP, which integrates precise US‐mediated ROS release control, ZBP1 gene regulation, and the improvement of the hypoxic microenvironment, to address both tumor treatment and bone regeneration in breast cancer bone metastasis. The gene discussed is ZBP1; the disease is neoplasm.